Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0ZC
|
|||
| Drug Name |
PMID28766366-Compound-Scheme15-3
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
LYTIX BIOPHARMA AS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H7N3O3S
|
|||
| Canonical SMILES |
CC(=O)NC1=NC2=C(S1)C=C(C=C2)[N+](=O)[O-]
|
|||
| InChI |
1S/C9H7N3O3S/c1-5(13)10-9-11-7-3-2-6(12(14)15)4-8(7)16-9/h2-4H,1H3,(H,10,11,13)
|
|||
| InChIKey |
XARDSBCDZPSYTN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 80395-50-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.